Scientific News: Oculis Appoints Björn Tackenberg As Chief Scientific Officer To Expand Neurology Drug Development

Choose a language:

Science Daily Reports

Details: Written by Bing News Search Results; Category: Science Daily Reports; Published: 03 November 2026; Created: 03 November 2026; Last Updated: 03 November 2026

Oculis Holding, a biopharmaceutical company developing therapies for neuro-ophthalmology and ophthalmology, has appointed Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer.
Original Image Link
Source:pulse2.com

Posted: 2026-11-03 01:46:00

Get Full News Story On Bing Science News Network

More News From This Category
Scientific News: Boston Scientific Watchman study pitches simpler drug regimens after LAAO procedures
Wed, 04 Nov 2026 20:07:28 +0000

The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood thinner regimens.
Original Image Link
Source:www.massdevice.com

Scientific News: Immuto Scientific to Present Structural Surfaceomics Data on Novel Drug Targets for CRC and AML at ENA 2026 and ASH 2026
Wed, 04 Nov 2026 17:07:26 +0000

Immuto Scientific to Present Structural Surfaceomics Data on Novel Drug Targets for CRC and AML at ENA 2026 and ASH 2026 ...
Original Image Link
Source:finance.yahoo.com

Scientific News: Why Effective Program Management Is the Engine of Scientific Research
Wed, 04 Nov 2026 14:07:30 +0000

Program managers, spread across the science agencies, have become an essential part of the engine of successful scientific research.
Original Image Link
Source:issues.org

Scientific News: Should You Pick Boston Scientific Stock Over Its Competitors?
Wed, 04 Nov 2026 11:07:23 +0000

Boston Scientific (BSX) stock lost 56.8% in the year to November 3, 2026, marking the worst return in a peer group of six health care companies that includes Medtronic and Stryker. The stock now ...
Original Image Link
Source:finance.yahoo.com

Scientific News: Boston Scientific (BSX) Secures $455 Million For A Next Generation Heart Pump
Wed, 04 Nov 2026 11:07:23 +0000

Boston Scientific (NYSE: BSX) agreed a co-funding partnership with Blackstone Life Sciences to develop the VITALYST next-generation heart pump for cardiogenic shock. The VITALYST device marks the ...
Original Image Link
Source:finance.yahoo.com

Related Bing News Results
Cows, Sheep, Pigs News
Mon, 03 Aug 2026 17:00:00 GMT
Apr. 1, 2026 Scientists uncovered a rare baby dinosaur in South Korea and named it Doolysaurus after a famous cartoon character. Using cutting-edge CT scans, they discovered hidden bones—including a .

Mind & Brain News
Tue, 03 Nov 2026 16:00:00 GMT
Nov. 3, 2026 A new study suggests that ultra-processed foods may influence children's developing brains in ways that encourage weight gain. Researchers from USC studied 46 children ages 7 to 10 and ...

🔎 Search This Topic on Popular Platforms